Bionano Genomics Inc [NASDAQ: BNGO] gained 24.05% on the last trading session, reaching $0.32 price per share at the time.
If compared to the average trading volume of 4.40M shares, BNGO reached a trading volume of 85226148 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Bionano Genomics Inc [BNGO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BNGO shares is $1.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BNGO stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Ladenburg Thalmann have made an estimate for Bionano Genomics Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on November 15, 2024. The new note on the price target was released on September 10, 2024, representing the official price target for Bionano Genomics Inc stock. Previously, the target price had yet another raise to $4, while Scotiabank analysts kept a Sector Outperform rating on BNGO stock.
The Average True Range (ATR) for Bionano Genomics Inc is set at 0.04, with the Price to Sales ratio for BNGO stock in the period of the last 12 months amounting to 1.20. The Price to Book ratio for the last quarter was 0.57, with the Price to Cash per share for the same quarter was set at 0.18.
Trading performance analysis for BNGO stock
Bionano Genomics Inc [BNGO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 46.62. With this latest performance, BNGO shares gained by 33.63% in over the last four-week period, additionally sinking by -42.28% over the last 6 months – not to mention a drop of -82.88% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BNGO stock in for the last two-week period is set at 65.25, with the RSI for the last a single of trading hit 70.88, and the three-weeks RSI is set at 59.78 for Bionano Genomics Inc [BNGO]. The present Moving Average for the last 50 days of trading for this stock 0.2546, while it was recorded at 0.2713 for the last single week of trading, and 0.5856 for the last 200 days.
Bionano Genomics Inc [BNGO]: A deeper dive into fundamental analysis
Bionano Genomics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.99 and a Current Ratio set at 1.43.
An analysis of Institutional ownership at Bionano Genomics Inc [BNGO]
There are presently around $12.81%, or 12.83%% of BNGO stock, in the hands of institutional investors.
